UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current pharmaceutical design, ISSN 1381-6128, 04/2011, Volume 17, Issue 10, pp. 1002 - 1024
G protein-coupled receptor | Neuroprotection | Stroke | Bioactive conformation | Traumatic brain injury | PACAP | Peptide drug design | VIP | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Neuroprotective Agents - therapeutic use | Receptors, G-Protein-Coupled - metabolism | Apoptosis - drug effects | Brain Injuries - drug therapy | Humans | Astrocytes - pathology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Drug Discovery - methods | Nerve Growth Factors - metabolism | Brain Ischemia - immunology | Brain Injuries - immunology | Neuroprotective Agents - adverse effects | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Cytokines - immunology | Astrocytes - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Brain Ischemia - drug therapy | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Brain Ischemia - pathology | Brain Injuries - pathology | Astrocytes - metabolism | Drugs | Cytokines | Astrocytes | Macromolecules | Inflammation | Drug development | Neuroprotective agents | Blood | Microglia | Pituitary adenylate cyclase-activating polypeptide | Chemical modification | Neurotransmitters | Side effects | Molecular modelling | Ischemia | Pharmacokinetics | Apoptosis
Journal Article
British journal of pharmacology, ISSN 0007-1188, 05/2012, Volume 166, Issue 1, pp. 4 - 17
agonists and antagonists | VPAC1 receptor | PACAP | signal transduction | VPAC2 receptor | accessory proteins | class B GPCR | VIP | splice variant | PAC1 receptor | PAC | receptor | VPAC | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Central Nervous System - physiology | Receptors, Vasoactive Intestinal Peptide - metabolism | Vasoactive Intestinal Peptide - metabolism | Immunity - physiology | Animals | Humans | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Central Nervous System - physiopathology | Inflammation - physiopathology | Pituitary gland | Growth hormones | Pharmacology | Polypeptides | Index Medicus | Reviews | Themed Section
Journal Article
Neurobiology of aging, ISSN 0197-4580, 2014, Volume 35, Issue 9, pp. 2064 - 2071
Neurology | Internal Medicine | Mitochondrial respiration | PACAP | Alzheimer's disease | SIRT3 | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Alzheimer Disease - etiology | Neurons - pathology | Neuroprotective Agents | Sirtuin 3 - metabolism | Humans | Molecular Targeted Therapy | Brain - metabolism | Mitochondria - genetics | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Amyloid beta-Peptides - metabolism | Neurons - metabolism | Brain - cytology | Gene Expression | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Amyloid beta-Peptides - toxicity | Cells, Cultured | Alzheimer Disease - drug therapy | Mice, Transgenic | Signal Transduction - genetics | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Animals | Nerve Growth Factors | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Signal Transduction - physiology | Alzheimer Disease - genetics | Mitochondria - physiology | Sirtuin 3 - physiology | Index Medicus
Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 2015, Volume 80, Issue 12, pp. 955 - 964
Psychiatry | Model | Anhedonia | Rat | Social interaction | Pituitary adenylate cyclase–activating peptide (PACAP) | Attention | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Rats | Male | Rats, Sprague-Dawley | Motivation - drug effects | Animals | Anhedonia - drug effects | Social Behavior | Neurotransmitter Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Attention - drug effects | Behavior, Animal - drug effects | Neurotransmitter Agents - administration & dosage | Pituitary Adenylate Cyclase-Activating Polypeptide - administration & dosage | Disease Models, Animal | Social aspects | Anxiety | Index Medicus | social interaction | attention | model | pituitary adenylate cyclase-activating peptide OR PACAP | rat | anhedonia
Journal Article
Pharmacological reviews, ISSN 0031-6997, 09/2009, Volume 61, Issue 3, pp. 283 - 357
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Animals | Humans | Pituitary Adenylate Cyclase-Activating Polypeptide - chemistry | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - chemistry | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide - physiology | Index Medicus | Life Sciences | Neurons and Cognition
Journal Article